Limitations, agreements, and source contact

Study of Velcade® and Bone Formation in Patients With Relapsed/Refractory Multiple Myeloma · Source last updated 2012-04-26

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

true

limitations And Caveats

description

Early termination due to difficulty in accruing participants.

point Of Contact

email

pettynathanm@uams.edu

organization

University of Arkansas for Medical Sciences, Myeloma Institute

phone

501-526-6990

phone Ext

2461

title

Nathan M. Petty

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice